Introduction

This week we've got two more interesting articles from the most recent regular issue of the journal. Amaloidosis is a group of conditions defined by extra cellular deposition of insoluble proteins that can lead to multi organ disfunction and failure. Advances in amori and nuclear medicine have provided greater specificity for the diagnosis of amaloid related pathology involving the central nervous system and the heart. The availability of novel therapeutics that target ameloid protein fibriles, such as trans thyreton and the new elsheimers drugs, hilats.